Researchers evaluated patient perspectives on the value of oncology navigation services and their willingness to pay for these support programs.

This multicenter study identifies key clinical and sociodemographic factors associated with fear of cancer recurrence in breast cancer survivors.

Investigators sought to model the effects of relabeling GG1 prostate cancer as precancerous on prostate cancer mortality in the US.

CPX-351 improved overall survival among older patients with myelodysplastic-related AML who undergo hematopoietic transplantation. CPX-351 treatment resulted in improved overall survival (OS) among ...

In this systematic review, researchers aimed to analyze the uptake of breast cancer risk management strategies, including prophylactic mastectomy, intensive surveillance, or no active strategy, in ...

Patients exposed to vitamin D showed significantly longer treatment-free survival than nonusers, with median durations of 147 vs 82 months.

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

Lung transplantation can prolong survival for select patients with medically refractory, lung-limited, stage IV non-small cell lung cancer (NSCLC), according to ...

Outpatient monitoring of CAR T-cell therapy reduces healthcare resource utilization and hospital days without impacting 30-day mortality, finds ASCO study.

A real-world analysis investigates the impact of concurrent GLP-1 RA use on long-term survival and the safety profile of patients with solid and hematologic malignancies receiving immune checkpoint ...

Using individual patient data from phase 2 and 3 trials, investigators analyzed the value of pathologic complete response vs ctDNA clearance after neoadjuvant immunotherapy or perioperative ...

Targeted therapies may improve survival in these patients by concurrently managing immune dysregulation and the leukemic clone.